BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37436061)

  • 21. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
    Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
    Sun B; Han Y; Cai H; Huang H; Xuan Y
    Cell Oncol (Dordr); 2021 Feb; 44(1):179-192. PubMed ID: 32930970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of microRNA-135b-5p protects against myocardial ischemia/reperfusion injury by activating JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia.
    Xie XJ; Fan DM; Xi K; Chen YW; Qi PW; Li QH; Fang L; Ma LG
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28522550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
    Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
    Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1α.
    Liu Y; Zhang J; Sun X; Li M
    Sci Rep; 2016 Jun; 6():28329. PubMed ID: 27325313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway.
    Choi HS; Kim JH; Kim SL; Deng HY; Lee D; Kim CS; Yun BS; Lee DS
    Mol Carcinog; 2018 Nov; 57(11):1467-1479. PubMed ID: 29964299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Betavulgarin Isolated from Sugar Beet (
    Liu R; Choi HS; Zhen X; Kim SL; Kim JH; Ko YC; Yun BS; Lee DS
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 33. Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.
    Finlay-Schultz J; Cittelly DM; Hendricks P; Patel P; Kabos P; Jacobsen BM; Richer JK; Sartorius CA
    Oncogene; 2015 Jul; 34(28):3676-87. PubMed ID: 25241899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.
    Lu YC; Cheng AJ; Lee LY; You GR; Li YL; Chen HY; Chang JT
    Sci Rep; 2017 May; 7(1):2042. PubMed ID: 28515423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGβ8- JAK2/STAT3 axis.
    Song Q; Liu B; Li X; Zhang Q; Cao L; Xu M; Meng Z; Wu X; Xu K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):494-500. PubMed ID: 29746867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.
    Ma Y; Yan F; Wei W; Deng J; Li L; Liu L; Sun J
    Cell Cycle; 2019 Oct; 18(20):2757-2769. PubMed ID: 31438772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.
    Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC
    Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.